Advancements in Spasticity Management: The Promise of Intrathecal Baclofen

Intrathecal Baclofen (ITB) is revolutionizing spasticity management for patients with cerebral palsy, multiple sclerosis, and spinal cord injuries. This targeted treatment offers effective relief from increased muscle tone and exaggerated reflexes, improving mobility and quality of life. With its lower systemic side effects compared to traditional therapies, ITB is a promising option for those with severe spasticity. Ongoing research continues to enhance our understanding of ITB’s long-term benefits, making it a vital consideration for healthcare providers.